116 related articles for article (PubMed ID: 23022711)
1. Parental history of premature coronary artery disease does not affect plasma levels of asymmetric dimethylarginine in young healthy adults.
Surdacki A; Zawiślak B; Rakowski T; Wieczorek-Surdacka E; Fedak D; Dubiel JS
Pol Arch Med Wewn; 2012; 122(10):487-93. PubMed ID: 23022711
[TBL] [Abstract][Full Text] [Related]
2. Asymmetrical dimethylarginine: a novel risk factor for coronary artery disease.
Lu TM; Ding YA; Charng MJ; Lin SJ
Clin Cardiol; 2003 Oct; 26(10):458-64. PubMed ID: 14579916
[TBL] [Abstract][Full Text] [Related]
3. Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study.
Kruszelnicka O; Surdacki A; Golay A
Cardiovasc Diabetol; 2013 Oct; 12():145. PubMed ID: 24103320
[TBL] [Abstract][Full Text] [Related]
4. Relations between markers of renal function, coronary risk factors and the occurrence and severity of coronary artery disease.
Wang J; Sim AS; Wang XL; Salonikas C; Moriatis M; Naidoo D; Wilcken DE
Atherosclerosis; 2008 Apr; 197(2):853-9. PubMed ID: 17826782
[TBL] [Abstract][Full Text] [Related]
5. AGXT2 and DDAH-1 genetic variants are highly correlated with serum ADMA and SDMA levels and with incidence of coronary artery disease in Egyptians.
Amir M; Hassanein SI; Abdel Rahman MF; Gad MZ
Mol Biol Rep; 2018 Dec; 45(6):2411-2419. PubMed ID: 30284143
[TBL] [Abstract][Full Text] [Related]
6. Relationship of asymmetric dimethylarginine (ADMA) with extent and functional severity of coronary atherosclerosis.
Mangiacapra F; Conte M; Demartini C; Muller O; Delrue L; Dierickx K; Di Sciascio G; Trimarco B; De Bruyne B; Wijns W; Bartunek J; Barbato E
Int J Cardiol; 2016 Oct; 220():629-33. PubMed ID: 27391005
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients.
Turiel M; Atzeni F; Tomasoni L; de Portu S; Delfino L; Bodini BD; Longhi M; Sitia S; Bianchi M; Ferrario P; Doria A; De Gennaro Colonna V; Sarzi-Puttini P
Rheumatology (Oxford); 2009 Jul; 48(7):834-9. PubMed ID: 19465588
[TBL] [Abstract][Full Text] [Related]
8. Plasma asymmetric dimethylarginine in active rheumatoid arthritis: links with oxidative stress and inflammation.
Kwaśny-Krochin B; Głuszko P; Undas A
Pol Arch Med Wewn; 2012; 122(6):270-6. PubMed ID: 22549098
[TBL] [Abstract][Full Text] [Related]
9. Coronary flow reserve and asymmetric dimethylarginine levels: new measurements for identifying subclinical atherosclerosis in patients with psoriatic arthritis.
Atzeni F; Sarzi-Puttini P; Sitia S; Tomasoni L; Gianturco L; Battellino M; Boccassini L; De Gennaro Colonna V; Marchesoni A; Turiel M
J Rheumatol; 2011 Aug; 38(8):1661-4. PubMed ID: 21632673
[TBL] [Abstract][Full Text] [Related]
10. Asymmetric and symmetric dimethylarginine are associated with coronary artery lesions in Kawasaki disease.
Huang YH; Tain YL; Lee CP; Kuo HC
J Pediatr; 2014 Aug; 165(2):295-9. PubMed ID: 24874168
[TBL] [Abstract][Full Text] [Related]
11. Association of asymmetric dimethylarginine levels with treadmill-stress-test-derived prognosticators.
Deftereos S; Bouras G; Tsounis D; Papadimitriou C; Hatzis G; Raisakis K; Panagopoulou V; Kaoukis A; Ioannidis A; Deftereos G; Kossyvakis C; Manolis AS; Alexopoulos D; Stefanadis C; Cleman MW; Giannopoulos G
Clin Biochem; 2014 May; 47(7-8):593-8. PubMed ID: 24525256
[TBL] [Abstract][Full Text] [Related]
12. Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease.
Wang J; Sim AS; Wang XL; Salonikas C; Naidoo D; Wilcken DE
Atherosclerosis; 2006 Feb; 184(2):383-8. PubMed ID: 15939423
[TBL] [Abstract][Full Text] [Related]
13. Increased symmetric dimethylarginine, but not asymmetric dimethylarginine, concentrations are associated with transient myocardial ischemia and predict outcome.
Szabo Z; Bartha E; Nagy L; Molnar T
J Int Med Res; 2020 Jun; 48(6):300060520920439. PubMed ID: 32529878
[TBL] [Abstract][Full Text] [Related]
14. Asymmetric Dimethylarginine versus Proton Pump Inhibitors Usage in Patients with Stable Coronary Artery Disease: A Cross-Sectional Study.
Kruszelnicka O; Świerszcz J; Bednarek J; Chyrchel B; Surdacki A; Nessler J
Int J Mol Sci; 2016 Apr; 17(4):454. PubMed ID: 27092494
[TBL] [Abstract][Full Text] [Related]
15. Asymmetric dimethylarginine levels in thyroid diseases.
Arikan E; Karadag CH; Guldiken S
J Endocrinol Invest; 2007 Mar; 30(3):186-91. PubMed ID: 17505150
[TBL] [Abstract][Full Text] [Related]
16. Effects of coronary revascularization with or without cardiopulmonary bypass on plasma levels of asymmetric dimethylarginine.
Cziráki A; Ajtay Z; Németh Á; Lenkey Z; Sulyok E; Szabados S; Alotti N; Martens-Lobenhoffer J; Szabó C; Bode-Böger SM
Coron Artery Dis; 2011 Jun; 22(4):245-52. PubMed ID: 21383621
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between plasma asymmetrical dimethylarginine and coronary artery disease].
Song Y; Qu XF; Yu YW; Luan TZ; Li JJ; Guo H; Yu Y
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1527-30. PubMed ID: 17785101
[TBL] [Abstract][Full Text] [Related]
18. [Relation of asymmetric dimethylarginine levels with conventional risk score systems in the healthy subjects with positive family history for coronary artery disease].
Satılmışoğlu H; Ozhan H; Albayrak S; Kaya A; Erden I; Yazıcı M
Anadolu Kardiyol Derg; 2011 Mar; 11(2):114-8. PubMed ID: 21285018
[TBL] [Abstract][Full Text] [Related]
19. Detrimental effects of a bout of physical exercise on circulating endogenous inhibitors of endothelial function in patients with coronary artery disease.
Ilic MD; Pavlovic R; Lazarevic G; Zivanovic S; Cvetkovic T; Kocic G; Ilic S; Ambrosio G
J Cardiovasc Med (Hagerstown); 2017 Aug; 18(8):610-616. PubMed ID: 27168139
[TBL] [Abstract][Full Text] [Related]
20. Elevation of asymmetrical dimethylarginine (ADMA) and coronary artery disease in men with erectile dysfunction.
Maas R; Wenske S; Zabel M; Ventura R; Schwedhelm E; Steenpass A; Klemm H; Noldus J; Böger RH
Eur Urol; 2005 Dec; 48(6):1004-11; discussion 1011-2. PubMed ID: 16139418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
